BDTX
USDBlack Diamond Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$3.850
Máximo
$3.860
Mínimo
$3.620
Volumen
0.96M
Fundamentos de la Empresa
Capitalización de Mercado
206.1M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.92M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
HC Wainwright & Co. Maintains Buy on Black Diamond Therapeutic, Lowers Price Target to $10
HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic with a Buy and lowers the price target from $12 to $10.
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Enrollment completed for the Phase 2 trial of silevertinib (BDTX-1535) in 1L patients with non-classical EGFRm NSCLC (n=43); ORR and preliminary DOR data on track for Q4 2025Exploring partnership opportunities to advance
Acciones Relacionadas
ANNX
Annexon Inc.
CNP
CenterPoint Energy Inc (Holding Co)
PNI
Pimco New York Municipal Income Fund II Common Shares of Beneficial Interest
MITN
AG Mortgage Investment Trust Inc. 9.500% Senior Notes due 2029
GOOGL
Alphabet Inc.
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.